Literature DB >> 20043722

Genetic basis of Parkinson disease.

Georgia Xiromerisiou1, Efthimios Dardiotis, Vaïa Tsimourtou, Persa Maria Kountra, Konstantinos N Paterakis, Eftychia Z Kapsalaki, Kostas N Fountas, Georgios M Hadjigeorgiou.   

Abstract

Over the past few years, considerable progress has been made in understanding the molecular mechanisms of Parkinson disease (PD). Mutations in certain genes are found to cause monogenic forms of the disorder, with autosomal dominant or autosomal recessive inheritance. These genes include alpha-synuclein, parkin, PINK1, DJ-1, LRRK2, and ATP13A2. The monogenic variants are important tools in identifying cellular pathways that shed light on the pathogenesis of this disease. Certain common genetic variants are also likely to modulate the risk of PD. International collaborative studies and meta-analyses have identified common variants as genetic susceptibility risk/protective factors for sporadic PD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20043722     DOI: 10.3171/2009.10.FOCUS09220

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  11 in total

Review 1.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 2.  Parkinson's disease: what the model systems have taught us so far.

Authors:  Swagata Ghatak; Dorit Trudler; Nima Dolatabadi; Rajesh Ambasudhan
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 3.  New insights on Parkinson's disease genes: the link between mitochondria impairment and neuroinflammation.

Authors:  Dorit Trudler; Yuval Nash; Dan Frenkel
Journal:  J Neural Transm (Vienna)       Date:  2015-04-17       Impact factor: 3.575

4.  Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction.

Authors:  Elena Miñones-Moyano; Marc R Friedländer; Joan Pallares; Birgit Kagerbauer; Sílvia Porta; Georgia Escaramís; Isidre Ferrer; Xavier Estivill; Eulàlia Martí
Journal:  RNA Biol       Date:  2013-05-01       Impact factor: 4.652

5.  Analysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 gene in Parkinson's disease patients in Xinjiang Uygur and Han ethnic groups.

Authors:  Guihua Li; Zhenzhong Zhang; Huan Xia; Xinling Yang
Journal:  Med Sci Monit       Date:  2014-11-06

6.  Low Level of Autophagy-Related Gene 10 (ATG10) Expression in the 6-Hydroxydopamine Rat Model of Parkinson's Disease

Authors:  Marzieh Shams Nooraei; Ali Noori-Zadeh; Shahram Darabi; Farzad Rajaei; Zohreh Golmohammadi; Hojjat Allah Abbaszadeh
Journal:  Iran Biomed J       Date:  2017-07-23

Review 7.  SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration.

Authors:  Pamela Milani; Giulia Ambrosi; Omar Gammoh; Fabio Blandini; Cristina Cereda
Journal:  Oxid Med Cell Longev       Date:  2013-07-28       Impact factor: 6.543

8.  BAG5 protects against mitochondrial oxidative damage through regulating PINK1 degradation.

Authors:  Xuejing Wang; Jifeng Guo; Erkang Fei; Yingfeng Mu; Shuang He; Xiangqian Che; Jieqiong Tan; Kun Xia; Zhuohua Zhang; Guanghui Wang; Beisha Tang
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

Review 9.  Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity.

Authors:  Prashant Tarale; Tapan Chakrabarti; Saravanadevi Sivanesan; Pravin Naoghare; Amit Bafana; Kannan Krishnamurthi
Journal:  Biomed Res Int       Date:  2016-05-26       Impact factor: 3.411

Review 10.  Risk Factor Genes in Patients with Dystonia: A Comprehensive Review.

Authors:  Vasileios Siokas; Athina-Maria Aloizou; Zisis Tsouris; Amalia Michalopoulou; Alexios-Fotios A Mentis; Efthimios Dardiotis
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.